The plethora of data available from electronic health records, claims systems, registries and from patients themselves is an unprecedented opportunity to modernize and augment clinical trials, while improving the current drug development process through the use of real-world evidence.
That’s the conclusion of a new report released Thursday by the Bipartisan Policy Center, which contends that real-world evidence can only be derived from real-world data gathered from sources outside of randomized controlled trials. The best data can come from sources such as EHRs, because it reflects the actual experiences of patients during routine care.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access